Found: 67
Select item for more details and to access through your institution.
Optimized dual-time-window protocols for quantitative [<sup>18</sup>F]flutemetamol and [<sup>18</sup>F]florbetaben PET studies.
- Published in:
- EJNMMI Research, 2013, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0499-4
- By:
- Publication type:
- Article
Strategies to reduce sample sizes in Alzheimer's disease primary and secondary prevention trials using longitudinal amyloid PET imaging.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00819-2
- By:
- Publication type:
- Article
A data-driven study of Alzheimer's disease related amyloid and tau pathology progression.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 12, p. 4935, doi. 10.1093/brain/awad232
- By:
- Publication type:
- Article
Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individuals.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2021, v. 13, n. 1, p. 1, doi. 10.1002/dad2.12216
- By:
- Publication type:
- Article
White matter microstructure disruption in early stage amyloid pathology.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2021, v. 13, n. 1, p. 1, doi. 10.1002/dad2.12124
- By:
- Publication type:
- Article
Comparison of static and dynamic analysis techniques for longitudinal analysis of amyloid PET: Neuroimaging / Optimal neuroimaging measures for tracking disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045991
- By:
- Publication type:
- Article
Tau‐first subtype of Alzheimer's disease progression consistently identified through PET and CSF: Neuroimaging: Understanding tau progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045412
- By:
- Publication type:
- Article
Converging evidence for a "gray‐zone" of amyloid burden and its relevance: The value of amyloid PET beyond dichotomization.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044786
- By:
- Publication type:
- Article
A multi‐study analysis of the spatial‐temporal progression of amyloid deposition and its utility for longitudinal studies: The value of amyloid PET beyond dichotomization.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044707
- By:
- Publication type:
- Article
Current status and quantitative results of the AMYPAD prognostic and natural history study: Neuroimaging / Optimal neuroimaging measures for tracking disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044711
- By:
- Publication type:
- Article
White matter integrity disruption in early amyloid accumulators: Neuroimaging / Optimal neuroimaging measures for early detection.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043021
- By:
- Publication type:
- Article
Examining centiloid quantification against visual assessment using [18F]flutemetamol PET: The value of amyloid PET beyond dichotomization.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042653
- By:
- Publication type:
- Article
Baseline features of the AMYPAD Diagnostic and Patient Management Study (DPMS) participants: Neuroimaging / differential diagnosis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042628
- By:
- Publication type:
- Article
Dynamic PET imaging reduces sample sizes to detect longitudinal amyloid accumulation: Neuroimaging / Optimal neuroimaging measures for tracking disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042623
- By:
- Publication type:
- Article
Impact of the disclosure of amyloid‐PET results to patients with subjective cognitive decline: the AMYPAD Diagnostic and Patient Management Study (DPMS): Neuroimaging / Normal brain aging.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.040952
- By:
- Publication type:
- Article
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 5, p. 750, doi. 10.1002/alz.12069
- By:
- Publication type:
- Article
P4‐307: THE ADDED VALUE OF QUANTITATIVE AMYLOID PET IN DETERMINING ALZHEIMER'S DISEASE (AD) DEMENTIA RISK: THE AMYPAD PROGNOSTIC AND NATURAL HISTORY STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1408, doi. 10.1016/j.jalz.2019.06.3977
- By:
- Publication type:
- Article
P3‐373: AMYPAD‐DPMS PRELIMINARY RESULTS: PARTICIPANTS' BASELINE FEATURES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1090, doi. 10.1016/j.jalz.2019.06.3406
- By:
- Publication type:
- Article
P1‐421: VOXEL‐BASED AMYLOID PET STAGING FOR THE WHOLE ALZHEIMER'S DISEASE CONTINUUM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P425, doi. 10.1016/j.jalz.2019.06.1026
- By:
- Publication type:
- Article
P1‐350: HIPPOCAMPAL INTRINSIC CONNECTIVITY SUPPORTS COGNITIVE RESERVE IN AMYLOID‐POSITIVE COGNITIVELY NORMAL SUBJECTS AND ALZHEIMER'S DISEASE PATIENTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P384, doi. 10.1016/j.jalz.2019.06.905
- By:
- Publication type:
- Article
IC‐P‐015: VOXEL‐BASED AMYLOID PET STAGING FOR THE WHOLE ALZHEIMER'S DISEASE CONTINUUM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P24, doi. 10.1016/j.jalz.2019.06.4177
- By:
- Publication type:
- Article
AMYPAD Diagnostic and Patient Management Study: Rationale and design.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 3, p. 388, doi. 10.1016/j.jalz.2018.09.003
- By:
- Publication type:
- Article
P3‐355: ASSESSMENT OF EARLY AMYLOID PATHOLOGY USING [<sup>18</sup>F]FLUTEMETAMOL POSITRON EMISSION TOMOGRAPHY: COMPARING VISUAL READ, SEMI‐QUANTITATIVE AND QUANTITATIVE METHODS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1221, doi. 10.1016/j.jalz.2018.06.1717
- By:
- Publication type:
- Article
P2‐445: EVENT‐BASED MODELING OF THE TEMPORAL ORDERING OF REGIONAL β‐AMYLOID DEPOSITION IN THE BRAIN.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P887, doi. 10.1016/j.jalz.2018.06.1137
- By:
- Publication type:
- Article
O2‐09‐05: EXTENSION AND VALIDATION OF AN AMYLOID STAGING MODEL: ASSOCIATIONS WITH CLINICAL MEASURES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P643, doi. 10.1016/j.jalz.2018.06.2692
- By:
- Publication type:
- Article
IC‐P‐182: EVENT‐BASED MODELING OF THE TEMPORAL ORDERING OF REGIONAL β‐AMYLOID DEPOSITION IN THE BRAIN.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P152, doi. 10.1016/j.jalz.2018.06.2249
- By:
- Publication type:
- Article
IC‐P‐005: ASSESSMENT OF EARLY AMYLOID PATHOLOGY USING [<sup>18</sup>F]FLUTEMETAMOL POSITRON EMISSION TOMOGRAPHY: COMPARING VISUAL READ, SEMI‐QUANTITATIVE AND QUANTITATIVE METHODS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P16, doi. 10.1016/j.jalz.2018.06.2069
- By:
- Publication type:
- Article
The spatial-temporal ordering of amyloid pathology and opportunities for PET imaging.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.235879
- By:
- Publication type:
- Article
Assessing Amyloid Pathology in Cognitively Normal Subjects Using <sup>18</sup>F-Flutemetamol PET: Comparing Visual Reads and Quantitative Methods.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 4, p. 541, doi. 10.2967/jnumed.118.211532
- By:
- Publication type:
- Article
Amyloid-PET imaging predicts functional decline in clinically normal individuals.
- Published in:
- Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01494-9
- By:
- Publication type:
- Article
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study.
- Published in:
- Alzheimer's Research & Therapy, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13195-023-01332-4
- By:
- Publication type:
- Article
Simulating the effect of cerebral blood flow changes on regional quantification of [ 18 F]flutemetamol and [ 18 F]florbetaben studies.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2021, v. 41, n. 3, p. 579, doi. 10.1177/0271678X20918029
- By:
- Publication type:
- Article
Regional associations of white matter hyperintensities and early cortical amyloid pathology.
- Published in:
- Brain Communications, 2022, v. 4, n. 3, p. 1, doi. 10.1093/braincomms/fcac150
- By:
- Publication type:
- Article
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2023, v. 80, n. 6, p. 548, doi. 10.1001/jamaneurol.2023.0997
- By:
- Publication type:
- Article
Quantification of amyloid PET for future clinical use: a state-of-the-art review.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3508, doi. 10.1007/s00259-022-05784-y
- By:
- Publication type:
- Article
Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2169, doi. 10.1007/s00259-020-05174-2
- By:
- Publication type:
- Article
Analysis of Psychological Symptoms Following Disclosure of Amyloid–Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 1, p. e2250921, doi. 10.1001/jamanetworkopen.2022.50921
- By:
- Publication type:
- Article
Test-Retest Variability of Relative Tracer Delivery Rate as Measured by [11C]PiB.
- Published in:
- Molecular Imaging & Biology, 2021, v. 23, n. 3, p. 335, doi. 10.1007/s11307-021-01606-z
- By:
- Publication type:
- Article
Correction to: Parametric Imaging of [11C]Flumazenil Binding in the Rat Brain.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Parametric Imaging of [<sup>11</sup>C]Flumazenil Binding in the Rat Brain.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of cerebral blood flow and amyloid load on SUVR bias.
- Published in:
- EJNMMI Research, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13550-022-00898-8
- By:
- Publication type:
- Article
[11C]PIB amyloid quantification: effect of reference region selection.
- Published in:
- EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-00714-1
- By:
- Publication type:
- Article
Amyloid predicts longitudinal atrophy in non‐demented individuals: Results from the AMYPAD Prognostic & Natural History study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082845
- By:
- Publication type:
- Article
Amyloid‐PET Centiloid quantification predicts cognitive functioning in a pre‐dementia population: findings from AMYPAD‐PNHS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078684
- By:
- Publication type:
- Article
Evaluating the global cortical Centiloid value for predicting functional decline.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074623
- By:
- Publication type:
- Article
Quantification supports visual assessment of challenging amyloid‐PET images.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074620
- By:
- Publication type:
- Article
Prediction of longitudinal cortical amyloid deposition based on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively unimpaired individuals: the role of APOE‐ε4.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076943
- By:
- Publication type:
- Article
Differential associations between regional amyloid PET and Alzheimer's disease polygenic risk scores.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.071266
- By:
- Publication type:
- Article
Amyloid‐PET Centiloid quantification predicts cognitive functioning in a pre‐dementia population: findings from AMYPAD‐PNHS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081826
- By:
- Publication type:
- Article
Differential associations between regional amyloid PET and Alzheimer's disease polygenic risk scores.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.071266
- By:
- Publication type:
- Article